|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/14/21 Arboretum Silverleaf Income Fd LP 10-Q 3/31/21 56:2M M2 Compliance LLC/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 209K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 21K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 21K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 17K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 17K
12: R1 Document and Entity Information HTML 45K
13: R2 Condensed Balance Sheets HTML 71K
14: R3 Condensed Balance Sheets (Parenthetical) HTML 20K
15: R4 Condensed Statements of Operations (Unaudited) HTML 84K
16: R5 Condensed Statements of Changes in Partners' HTML 37K
Equity (Deficit) (Unaudited)
17: R6 Condensed Statements of Cash Flows (Unaudited) HTML 89K
18: R7 Organization and Nature of Operations HTML 26K
19: R8 Summary of Significant Accounting Policies HTML 38K
20: R9 Related Party Transactions HTML 23K
21: R10 Investments in Finance Leases HTML 22K
22: R11 Investment in Equipment Subject to Operating HTML 24K
Leases
23: R12 Collateralized Loans Receivable HTML 21K
24: R13 Other Assets HTML 19K
25: R14 Loan Payable HTML 24K
26: R15 Fair Value of Financial Instruments HTML 26K
27: R16 Indemnifications HTML 20K
28: R17 Business Concentrations HTML 20K
29: R18 Geographic Information HTML 22K
30: R19 Commitments and Contingencies HTML 19K
31: R20 Covid-19 HTML 19K
32: R21 Subsequent Events HTML 19K
33: R22 Summary of Significant Accounting Policies HTML 69K
(Policies)
34: R23 Investments in Finance Leases (Tables) HTML 22K
35: R24 Investment in Equipment Subject to Operating HTML 24K
Leases (Tables)
36: R25 Collateralized Loans Receivable (Tables) HTML 21K
37: R26 Loan Payable (Tables) HTML 19K
38: R27 Fair Value of Financial Instruments (Tables) HTML 25K
39: R28 Organization and Nature of Operations (Details HTML 62K
Narrative)
40: R29 Summary of Significant Accounting Policies HTML 19K
(Details Narrative)
41: R30 Related Party Transactions (Details Narrative) HTML 52K
42: R31 Investments in Finance Leases - Schedule of Net HTML 25K
Investments in Finance Leases (Details)
43: R32 Investment in Equipment Subject to Operating HTML 19K
Leases (Details Narrative)
44: R33 Investment in Equipment Subject to Operating HTML 31K
Leases - Schedule of Composition of Equipment
Subject to Operating Leases of Partnership
(Details)
45: R34 Collateralized Loans Receivable - Schedule of HTML 37K
Future Principal Maturities (Details)
46: R35 Other Assets (Details Narrative) HTML 22K
47: R36 Loan Payable (Details Narrative) HTML 37K
48: R37 Loan Payable - Schedule of Future Maturities of HTML 20K
Loan Payable (Details)
49: R38 Fair Value of Financial Instruments - Schedule of HTML 23K
Fair Values of Financial Instruments (Details)
50: R39 Business Concentrations (Details Narrative) HTML 47K
51: R40 Commitments and Contingencies (Details Narrative) HTML 18K
52: R41 Covid-19 (Details Narrative) HTML 19K
53: R42 Subsequent Events (Details Narrative) HTML 19K
55: XML IDEA XML File -- Filing Summary XML 96K
54: EXCEL IDEA Workbook of Financial Reports XLSX 52K
6: EX-101.INS XBRL Instance -- alif-20210331 XML 439K
8: EX-101.CAL XBRL Calculations -- alif-20210331_cal XML 118K
9: EX-101.DEF XBRL Definitions -- alif-20210331_def XML 222K
10: EX-101.LAB XBRL Labels -- alif-20210331_lab XML 530K
11: EX-101.PRE XBRL Presentations -- alif-20210331_pre XML 378K
7: EX-101.SCH XBRL Schema -- alif-20210331 XSD 106K
56: ZIP XBRL Zipped Folder -- 0001493152-21-011492-xbrl Zip 63K
EXHIBIT 31.1
CERTIFICATION
I, Michael Miroshnikov, certify that:
| 1. | I have reviewed this quarterly report on Form 10-Q of Arboretum Silverleaf Income Fund, L.P.; |
| 2. | Based on my knowledge, this report does not contain any untrue statement of material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
| 4. | The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
| a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant , including its consolidated subsidiaries is made known to us by others within those entities, particularly during the period in which this report is being prepared; | |
| b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |
| c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | |
| d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
| 5. | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
| a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and | |
| b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
| Date: May 14, 2021 | |
| /s/ Michael Miroshnikov | |
| Michael Miroshnikov | |
| President | |
| (Principal Executive Officer) |
C:
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 5/14/21 | |||
| For Period end: | 3/31/21 | 10-K | ||
| List all Filings | ||||